This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Closing remarks
Arthritis Res Ther 2004, 6(Suppl 2):S44 doi:10.1186/ar998
No comments have yet been made on this article.
This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Arthritis Res Ther 2004, 6(Suppl 2):S44 doi:10.1186/ar998
No comments have yet been made on this article.
